Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood

Veterinary Journal

Volumn 190, Issue 1, 2011, Pages 165-168

  da Costa, A ^a   Oliveira, J T ^b   Gartner F ^b   Kohn, B ^a   Gruber, A D ^a   Klopfleisch, R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Breast cancer; Canine mammary tumors; Circulating tumor cells; PCR

Indexed keywords

CLDN7 PROTEIN; CYTOKERATIN 18; CYTOKERATIN 19; ELF3 PROTEIN; EPHRIN RECEPTOR B4; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; GELATINASE B; HERMES ANTIGEN; MASPIN; MUCIN 1; PROTEIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CIRCULATING TUMOR CELL; CONTROLLED STUDY; LEUKOCYTE; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL CIRCULATION; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOGS; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80053560584     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.09.027     Document Type: Article

References (8)

1. Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australia Medical Journal 1869, 14:146.
2. Hayes D.F., Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Miller M.C., Matera J., Allard W.J., Doyle G.V., Terstappen L.W. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clinical Cancer Research 2006, 12:4218-4224.
3. Klopfleisch R., Gruber A.D. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Veterinary Pathology 2009, 46:416-422.
4. Klopfleisch R., Schutze M., Gruber A.D. Downregulation of transforming growth factor beta (TGFbeta) and latent TGFbeta binding protein (LTBP)-4 expression in late stage canine mammary tumours. The Veterinary Journal 2010, 186:379-384.
5. Klopfleisch R., Klose P., Gruber A.D. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors. Veterinary Pathology 2010, 47:446-454.
6. Mostert B., Sleijfer S., Foekens J.A., Gratama J.W. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treatment Reviews 2009, 35:463-474.
7. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nature Reviews Cancer 2004, 4:448-456.
8. Ross A.A., Cooper B.W., Lazarus H.M., Mackay W., Moss T.J., Ciobanu N., Tallman M.S., Kennedy M.J., Davidson N.E., Sweet D., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993, 82:2605-2610.